| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ADP | Common Stock | Options Exercise | $234,889 | +1,383 | +35% | $169.84 | 5,282 | 01 Sep 2021 | Direct | F1 |
| transaction | ADP | Common Stock | Options Exercise | $55,285 | +515 | +9.7% | $107.35 | 5,797 | 01 Sep 2021 | Direct | F1 |
| transaction | ADP | Common Stock | Options Exercise | $54,298 | +370 | +6.4% | $146.75 | 6,167 | 01 Sep 2021 | Direct | F1 |
| transaction | ADP | Common Stock | Sale | $68,268 | -329 | -5.3% | $207.50 | 5,838 | 01 Sep 2021 | Direct | F1 |
| transaction | ADP | Common Stock | Sale | $87,150 | -420 | -7.2% | $207.50 | 5,418 | 01 Sep 2021 | Direct | F1 |
| transaction | ADP | Common Stock | Tax liability | $94,742 | -458 | -8.5% | $206.86 | 4,960 | 01 Sep 2021 | Direct | |
| transaction | ADP | Common Stock | Sale | $266,638 | -1,285 | -26% | $207.50 | 3,675 | 01 Sep 2021 | Direct | F1 |
| transaction | ADP | Common Stock | Sale | $45,002 | -219 | -6% | $205.49 | 3,456 | 02 Sep 2021 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ADP | Stock Option (Right to Buy) | Options Exercise | $55,285 | -515 | -100% | $107.35 | 0 | 01 Sep 2021 | Common Stock | 515 | $107.35 | Direct | F1 |
| transaction | ADP | Stock Option (Right to Buy) | Options Exercise | $54,298 | -370 | -33% | $146.75 | 741 | 01 Sep 2021 | Common Stock | 370 | $146.75 | Direct | F1 |
| transaction | ADP | Stock Option (Right to Buy) | Options Exercise | $234,889 | -1,383 | -33% | $169.84 | 2,766 | 01 Sep 2021 | Common Stock | 1,383 | $169.84 | Direct | F1 |
| transaction | ADP | Stock Option (Right to Buy) | Award | $0 | +7,947 | $0.000000 | 7,947 | 01 Sep 2021 | Common Stock | 7,947 | $206.86 | Direct |
| Id | Content |
|---|---|
| F1 | The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in September 2020. |